StockrabitBrowse analysts
Analyst questions

Sajal Kapoor

Antifragile Wealth
WINDLAS

Windlas Biotech Limited

All company calls
FY2027 Q1
11 Aug 2026
Open call
  1. Team, to be fair, the execution deserves acknowledgment. 14 consecutive quarters of record revenue is itself a clean execution. And I always say publicly, EBITDA alone is never the yardstick unless that EBITDA translates into solid cash flows. In Windlas, we have the cash flows and the balance sheet to show substance.

    Read in transcript